.BRIEF-U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's humira March 30, 2017 07:28 AM ET Reuters . BRIEF- U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's humira. *U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's Humira prescribing information. *U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's Humira prescribing information. Read more
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.